Caerus Us 1
UEI: RLHVUTFVW2X8
• CAGE: 9K0B4
Overview
Awardee Type
Parent
Company Description
Citeline is the leading provider of drug, device, company, clinical trial and market intelligence in the pharmaceutical and medtech markets.
Name
Caerus Us 1
Website
Headquarters
New York, NY
United States
United States
Most Recent Award
Jan. 1, 2025
Calculating
Federal contract recipient
CAERUS US 1 INC.
(UEI RLHVUTFVW2X8, CAGE 9K0B4)
is headquartered in New York NY.
Its primary registered NAICS is 513120 Periodical Publishers.
The corporation
was founded in February 2022 and
federally registered in
February 2023.
Federal Award Analysis
Caerus Us 1 federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
CAERUS US 1 INC.
UEI
RLHVUTFVW2X8
CAGE Code
9K0B4
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Feb. 3, 2022
Initial Registration
Feb. 28, 2023
Last Registration
Aug. 22, 2024
Registration Activation
Aug. 22, 2024
Registration Expiration
Aug. 14, 2025
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Accepts Credit Cards
Yes
People
Vendor contacts at Caerus Us 1
Contract Awards
Caerus Us 1 prime contract awards
Subcontract Awards
Caerus Us 1 subcontract awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Caerus Us 1